首页 | 本学科首页   官方微博 | 高级检索  
检索        

中药治疗溃疡性结肠炎的临床研究与进展
引用本文:吴撼平.中药治疗溃疡性结肠炎的临床研究与进展[J].中医临床研究,2012,4(8):115-116.
作者姓名:吴撼平
作者单位:湖南省冷水江市中医医院,湖南冷水江,417500
摘    要:目的:观察应用中药治疗溃疡性结肠炎的临床疗效,探讨中医中药在治疗溃疡性结肠炎方面的治疗进展。方法:将2010年10月~2011年10月入住我院的溃疡性结肠炎患者96例随机分为实验组和对照组,各为48例。实验组接受中医辨证施治联合中药保留灌肠治疗,对照组采用美沙拉嗪结合地塞米松灌肠常规疗法。比较两组治疗2个月后的临床症状、肠镜结果及不良反应的情况。结果:实验组采用治疗方案后的总体有效率95.8%,不良反应发生率为2.08%,对照组的总体有效率88.5%,不良反应发生率为12.5%,两组比较差异有显著性(P0.05)。结论:溃疡性结肠炎病人采用中药治疗方案比常规西医治疗的效果显著,疗效有优势值得进一步推广。

关 键 词:溃疡性结肠炎  中药

Clinical research and advances on treating ulcerative colitis in TCM
Abstract:Objective: To observe the application and the clinical efficacy of TCM in treating ulcerative colitis. Methods: 96 patients with ulcerative colitis who stay in hospital from October 2010 to October 2011 were randomly divided into experimental and control group. Experimental group received dialectical therapy combined with TCM retention enema, while the control group received conventional therapy alone with Mesalazine and Dexamethasone. The two groups were compared the clinical symptoms, endoscopic findings and the case of adverse reactions after 2 months of treatment. Results: The experimental group’s effective rate is 97.9%, the adverse reaction rate was2.08%, control group’s overall efficiency was 83.3%, adverse reactions was 12.5%, the difference was significant (P<0.05). Conclusion: Treating ulcerative colitis in TCM has a good effect, better than using single treatment with mesalazine, is worth being clinical further promotion.
Keywords:Ulcerative colitis  TCM
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号